Home >> Pharmaceuticals >> Food & Beverage >>

Bsim2 - Product Pipeline Review - 2015

Published: Apr-2015 | Format: PDF | Global Markets Direct | Number of pages: 16 | Code: MRS - 18300

Bsim2 - Product Pipeline Review - 2015


Global Markets Direct’s, ‘Bsim2 - Product Pipeline Review - 2015’, provides an overview of the Bsim2’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Bsim2’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


- The report provides brief overview of Bsim2 including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Bsim2’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Bsim2’s pipeline products

Reasons to buy

- Evaluate Bsim2’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Bsim2 in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Bsim2’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Bsim2 and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Bsim2
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Bsim2 and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Bsim2 Snapshot 4
Bsim2 Overview 4
Key Information 4
Key Facts 4
Bsim2 - Research and Development Overview 5
Key Therapeutic Areas 5
Bsim2 - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Bsim2 - Pipeline Products Glance 9
Bsim2 - Early Stage Pipeline Products 9
Discovery Products/Combination Treatment Modalities 9
Bsim2 - Drug Profiles 10
Small Molecules to Inhibit Transthyretin Related Amyloid Protein for Alzheimer's Disease 10
Product Description 10
Mechanism of Action 10
R&D Progress 10
Small Molecules to Inhibit Transthyretin Related Amyloid Protein for Familial Amyloidotic Cardiomyopathy 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
Small Molecules to Inhibit Transthyretin Related Amyloid Protein for Familial Amyloidotic Polyneuropathy 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
Bsim2 - Pipeline Analysis 13
Bsim2 - Pipeline Products by Molecule Type 13
Bsim2 - Locations And Subsidiaries 14
Head Office 14
Appendix 15
Methodology 15
Coverage 15
Secondary Research 15
Primary Research 15
Expert Panel Validation 15
Contact Us 15
Disclaimer 16

List of Tables
Bsim2, Key Information 4
Bsim2, Key Facts 4
Bsim2 - Pipeline by Indication, 2015 6
Bsim2 - Pipeline by Stage of Development, 2015 7
Bsim2 - Monotherapy Products in Pipeline, 2015 8
Bsim2 - Discovery, 2015 9
Bsim2 - Pipeline by Molecule Type, 2015 13

List of Figures
Bsim2 - Pipeline by Top 10 Indication, 2015 6

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)1500 View Pricing